# De-novo and acquired resistance to immune checkpoint targeting

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/de-novo-and-acquired-resistance-to-immune-checkpoint-targeting/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nicholas Syn,Michele W.L. Teng,Tony Mok,Ross A. Soo |
| Citations | 734 |
| DOI | 10.1016/s1470-2045(17)30607-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2772677509 |
| PMID | 29208439 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Ross A. Soo](https://scholariq.org/researchers/ross-a-soo/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.